Paper Chase #2: Variable vs Fixed Dose Steroids in COPD Exacerbation

Update: 2022-03-01

Description

March 2022

A personalized dose between 40-60mg showed reduction in additional steroid use and reduced antibiotic escalation

Steve Biederman, MD • Tom Robertson, MD

Comments

In Channel

One Minute Preceptor

2022-03-0121:58

Paper Chase #1: 7 vs 14 Days of Abx for Men with UTIs

2022-03-0106:46

Things I Do, But Should I? Office Spirometry

2022-03-0113:31

Paper Chase #2: Variable vs Fixed Dose Steroids in COPD Exacerbation

2022-03-0106:38

Runner Injuries

2022-03-0132:49

Circumcision Ethics

2022-03-0122:25

Paper Chase #3: De-Escalation of DAPT in ACS

2022-03-0107:44

Fever in Children 3-36 Months

2022-03-0123:32

Gender Affirming Care

2022-03-0126:04

Paper Chase #4: Intra-Articular PRP vs Placebo in Knee OA

2022-03-0106:06

The Big Picture: Becoming Doctors, 25 Years Later

2022-03-0127:04

Paper Chase #5: Quercetin Supplementation in Muscle Recovery

2022-03-0109:55

Mailbag

2022-03-0101:43

Race and Medicine in 2022: Sustaining the Movement

2022-02-2322:43

PECARN Pie: Pediatric COVID Outcomes - A Global Study from PERN

2022-02-1122:23

New Outpatient Treatment Options for Covid-19

2022-02-0226:20

Patient Access to Notes and Labs

2022-02-0116:47

Paper Chase #1: Antidepressant Use in Pregnancy

2022-02-0107:35

Breast Pumps - What PCPs Need to Know

2022-02-0119:30

Hair Loss and Scalp Dermatoses

2022-02-0120:28

00:00

Paper Chase #2: Variable vs Fixed Dose Steroids in COPD Exacerbation

#box-pro-ellipsis-176120911115246{-webkit-line-clamp:2;}Paper Chase #2: Variable vs Fixed Dose Steroids in COPD Exacerbation

Paper Chase #2: Variable vs Fixed Dose Steroids in COPD Exacerbation

Paper Chase #2: Variable vs Fixed Dose Steroids in COPD Exacerbation